Health Care·Health Care Supplies·$12.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.88 | N/A | +13.75% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $2.88 | N/A | +13.75% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on earnings but remained cautious about future revenue growth. They did not provide specific guidance for upcoming quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing initiatives aimed at improving operational efficiency.
Cooper Cos Inc's earnings report indicates a strong performance on the earnings front, with EPS exceeding expectations. The stock reacted positively, rising 0.82%, likely driven by the surprise in EPS. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BIOCRYST PHARMACEUTI
Mar 4, 2019